Menu Close

Trending

Why reshoring drug production means embracing continuous manufacturing
Clariness, DailyBreath partner to drive recruitment in asthma trials
J&J says it will stop selling all talc products next year
Cumulus’ gamified dry EEG system tops lab monitoring in trial
Dismay as UK ‘drags its heels’ on AZ’s COVID antibody Evusheld

FreeStyle Libre

Abbott_FreeStyle_libre_3_wearable

Digital/ News/ News/ News/ Patients

Abbott makes progress with wearable for diabetic ketoacidosis

, , , , , , , , 0 Comment

Abbott is already a big player in the wearable glucose-monitoring sector, and has started working on a new

X
Abbott makes progress with wearable for diabetic ketoacidosis
https://pharmaphorum.com/news/abbott-makes-progress-with-wearable-for-diabetic-ketoacidosis/
~ai-9d6a62d3-dfc0-4e08-82a5-ed2a25f94450_

Digital/ News/ News

Real-time Abbott glucose monitor available to NHS after UK launch

, , , , , , , 0 Comment

The latest version of Abbott’s FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible

X
Real-time Abbott glucose monitor available to NHS after UK launch
https://pharmaphorum.com/news/real-time-abbott-glucose-monitor-available-to-nhs-after-uk-launch/
glioblastoma

Articles/ Digital and Social Media/ Views and analysis

Digital Health Round-up – Is AI the future of cancer drug development?

, , , , , , , , 0 Comment

Does artificial intelligence hold the key to cancer drug R&D?

X
Digital Health Round-up – Is AI the future of cancer drug development?
https://pharmaphorum.com/views-and-analysis/digital-health-round-ai-future-cancer-drug-development/

Login

CONTINUE TO SITE >
X
Close in 10 seconds